Becton, Dickinson and Company’s BDX, or popularly known as BD, initiated the recall of its infusion pumps last month after customer reports indicated software issues, potentially leading to inaccurate ...
The Food and Drug Administration has posted a Class I notice about Becton Dickinson infusion pumps affected by compatibility issues with Cardinal Health Monoject syringes. Cardinal sent an urgent ...
SAN DIEGO, April 20 /PRNewswire-FirstCall/ -- A new report from KLAS, an independent health care vendor research firm, concluded the CareFusion (NYSE: CFN) Alaris ...
BD will pay a civil penalty to resolve charges it misled investors about risks associated with sales of its Alaris infusion pump, the Securities and Exchange Commission said. BD’s Alaris pumps are ...
The Alaris infusion system [Image courtesy of BD] BD (NYSE:BDX) announced a voluntary recall related to certain Alaris and Alaris infusion pump modules. Affected Alaris products may have been serviced ...
FRANKLIN LAKES, N.J., July 18, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on two voluntary recalls ...
The US Food and Drug Administration (FDA) has notified healthcare providers of a class 1 recall of CareFusion's Alaris PC unit (model 8015) with software version 9.12. The Alaris PC unit is the ...
BD (Becton, Dickinson and Company), a leading global medical technology company, announced that the updated BD Alaris Infusion System has received 510(k) clearance from the US Food and Drug ...
Washington, D.C.--(Newsfile Corp. - December 16, 2024) - The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback